RxDoctor Payments Data

Jonathan Miner, MD

Rheumatology · Philadelphia, PANPI 1639480528

Payments from drug & device makers

What this record shows

That places this record below the midpoint for rheumatology clinicians in PA, where the typical reported total is $1,951.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$3,771,691in research payments, 2019–2025

Across 13 payments — averaging $290,130 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$3.6M
  • Pfizer$134K
  • Sanofi US Services Inc.$39K

How this compares

$0 in reported general payments places this provider in the 5th percentile of 351 rheumatology providers in Pennsylvania.

See all rheumatology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$3,390
Medicare patients
22
Services billed
38

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydroxychloroquine Sulfate18$1,733
MethotrexateMethotrexate Sodium51$1,472
Gabapentin13$356
Sulfasalazine12$345
Prednisone41$317
Trazodone Hcl11$30

Paid to pharmacies, not to this prescriber.

Other rheumatology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →